Your session is about to expire
← Back to Search
Enstilar Foam for Nail Psoriasis
Study Summary
This trial will test a new foam medication to see if it is effective and safe in treating nail psoriasis.
- Psoriasis Nail
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had nail conditions like lichen planus or onychomycosis in the past.You have had specific treatment for your fingernail within the past 6 months before the screening.You have had plaque psoriasis or psoriatic arthritis in the past.The affected nail does not show signs of a dermatophyte fungus when tested with KOH.You are between 18 and 85 years old.You have a specific type of severe psoriasis called erythrodermic or pustular psoriasis.You have been treated for psoriasis with systemic medication for less than 6 months.You must have been diagnosed with psoriasis in your fingernails or toenails.You have had a previous injury or surgery on your fingernail.The doctor thinks you can use a skin treatment.
- Group 1: Enstilar Foam
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How is Enstilar Foam typically utilized to benefit patients?
"Enstilar Foam has been clinically demonstrated to effectively alleviate symptoms of nephrotic syndrome, malignant growths, neurological disorders and ophthalmia, in addition to sympathetic afflictions."
Does this research endeavor constitute a novel approach to its field?
"Since its inception in 2010, sponsored by Mantecorp Industria Quimica e Farmaceutica Ltd., Enstilar Foam has been subject to various clinical studies. The first trial involved 170 participants and the drug was granted Phase 3 approval shortly thereafter. Currently, there are 19 different trials underway for Enstilar Foam which occur across 57 cities located within 22 nations."
Is there an opportunity for me to join this experimental research?
"In order to participate in the trial, 20 individuals aged 18-85 who have a history of psoriasis or psoriatic arthritis must meet additional criteria: Having a diagnosis of nail psoriasis in fingernails/toenails."
Has the federal government given its seal of approval to Enstilar Foam?
"Due to its Phase 4 status, a score of 3 has been assigned for Enstilar Foam's safety. This assessment is based on the evidence that this treatment has already received regulatory approval."
Is there room for further participants in this research endeavor?
"Affirmative, the information on clinicaltrials.gov confirms that this research project is actively recruiting patients. Initially posted in November 1st 2021 and last modified on August 11th 2022, it requires 20 volunteers at a single medical centre."
How many individuals are being recruited for this trial?
"Affirmative. Clinicaltrials.gov records demonstrate that this research project, initially posted on November 1st 2021, is presently recruiting participants. Consequently, the team requires 20 people to join from one single location."
Does this research encompass elderly participants aged 85 or above?
"According to the rules of this clinical trial, candidates must fall between 18 years old and 85 in order to be considered for enrollment."
What other investigations have been conducted involving the use of Enstilar Foam?
"Currently, there are 19 investigations being conducted related to Enstilar Foam. Of which 5 have already entered Phase 3 of the clinical trial process. While most studies in Birmingham, Alabama focus on this foam treatment, across 125 sites it is possible to take part in these trials."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger